With the European Union’s (EU) new guideline on medical device vigilance taking effect Jan. 1, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) plans to release a revised guidance detailing how devicemakers and their authorized representatives should operate medical device postmarketing surveillance systems in the UK.
